Unlock instant, AI-driven research and patent intelligence for your innovation.

Antibacterial and combined antibacterial activity of nitrosourea compound

A streptozotocin, positive bacteria technology, applied in the direction of antibacterial drugs, organic active ingredients, medical preparations containing active ingredients, etc.

Active Publication Date: 2022-05-13
BEIJING CHILDRENS HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV +1
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Since 1960, streptozotocin has been mainly used for anti-tumor therapy and the establishment of animal models of type 2 diabetes, and its antibacterial activity research has been almost completely interrupted, especially the antibacterial activity of streptozotocin combined with other antibacterial drugs has not been found. to report

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibacterial and combined antibacterial activity of nitrosourea compound
  • Antibacterial and combined antibacterial activity of nitrosourea compound
  • Antibacterial and combined antibacterial activity of nitrosourea compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Embodiment 1 agar dilution method detects streptozotocin antibacterial MIC value

[0026] The tested strains were inoculated on agar culture dishes by drawing a line, and cultured overnight in a constant temperature incubator at 37°C. On the next day, pick at least 3 well-separated colonies with the same shape from the agar plate, inoculate them in appropriate broth medium, incubate at 35°C for 2-6 hours, and adjust the concentration of the bacteria solution to 0.5 McFarland turbidity using a turbidimeter. (1~2×10 8 CFU / mL) for use. Dilute the stock solution of streptozotocin with the corresponding diluent to various required concentrations in turn, add it to a 90mm sterile plate, then add the corresponding volume of MH agar with a graduated pipette, and fully mix the drug solution with the culture medium After homogenization, a drug-containing agar plate with a final concentration of streptozotocin in the range of 0.06-128 μg / mL was prepared for use. Dilute the 0.5 ...

Embodiment 2K-B

[0031] Embodiment 2K-B disc method combined drug susceptibility test

[0032] The tested strains were inoculated on agar culture dishes by drawing a line, and cultured overnight in a constant temperature incubator at 37°C. On the next day, pick at least 3 well-separated colonies with the same shape from the agar plate, inoculate them in appropriate broth medium, incubate at 35°C for 2-6 hours, and adjust the concentration of the bacteria solution to 0.5 McFarland turbidity using a turbidimeter. (1~2×10 8 CFU / mL), use a sterile cotton swab to dip in the bacterial solution, squeeze out the water lightly, spread it evenly on the MH agar medium, and dry the surface water for later use. The distance between the center points of the two discs is adjusted according to the drug sensitivity. If both drugs are sensitive, the distance is 24mm; if one of the two drugs is resistant and the other is sensitive, the distance is 15mm; if both drugs are resistant, the distance is 10mm. The MH ...

Embodiment 3

[0035] Embodiment 3 checkerboard method combined drug susceptibility test

[0036] The tested strains were inoculated on agar culture dishes by drawing a line, and cultured overnight in a constant temperature incubator at 37°C. On the next day, pick at least 3 well-separated colonies with the same shape from the agar plate, inoculate them in appropriate broth medium, incubate at 35°C for 2-6 hours, and adjust the concentration of the bacteria solution to 0.5 McFarland turbidity using a turbidimeter. (1~2×10 8 CFU / mL), and then diluted 20 times for use. The two compounds in the combined drug were respectively diluted horizontally (Drug A) and vertically (Drug B) in two round-bottom 96-well plates, and the diluted drug concentrations were 2 times the final experimental concentration, of which Add blank CAMH broth medium without drug after the last concentration gradient of each drug dilution. The diluted two drugs were completely combined at different concentrations, and adde...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses application of streptozotocin in antibacterial and combined antibacterial activity. The streptozotocin disclosed by the invention has broad-spectrum antibacterial activity, has antibacterial activity on drug-resistant gram-positive bacteria and gram-negative bacteria, and has accumulated or synergistic antibacterial activity on drug-resistant bacteria when being used together with other antibacterial drugs, so that the defects of current clinical drug varieties for resisting drug-resistant bacteria can be overcome, the curative effect is improved, and the application prospect is broad. The spreading of drug-resistant bacteria is reduced.

Description

technical field [0001] The invention relates to the field of biology, in particular to the application of streptozotocin antibacterial and combined antibacterial activity. Background technique [0002] Gram-negative (G - ) bacterial resistance is becoming more and more serious, among which Enterobacteriaceae (including Escherichia coli, Klebsiella pneumoniae, etc.) producing extended-spectrum β-lactamase (ESBL) and carbapenem-resistant bacteria , the lack of effective drugs, the difficulty of clinical treatment, had to make polymyxins, which were basically abandoned many years ago due to excessive nephrotoxicity and neurotoxicity, take on the current task of fighting multidrug resistance G - The task of the last line of defense against bacteria. However, polymyxin-resistant strains are also gradually emerging, especially the emergence of plasmid-mediated polymyxin resistance gene mcr-1 has further exacerbated the current situation of bacterial drug resistance. What is eve...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7024A61K31/7008A61K45/06A61K38/12A61P31/04
CPCA61K31/7008A61P31/04A61K38/12A61K2300/00Y02A50/30
Inventor 李玥游雪甫杨信怡姚开虎
Owner BEIJING CHILDRENS HOSPITAL AFFILIATED TO CAPITAL MEDICAL UNIV